A Validated Algorithm for Register-Based Identification of Patients with Relapse of Clinical Stage I Testicular Cancer

References

• Sørensen HT, Pedersen L, Jørgensen J, Ehrenstein V. Danish clinical quality databases – an important and untapped resource for clinical research. Clin Epidemiol. 2016;8:425–427. doi:10.2147/CLEP.S113265
   PubMed Web of Science ®Google Scholar
• Green A. Danish clinical databases: an overview. Scand J Public Health. 2011;39(7 Suppl):68–71. doi:10.1177/1403494811402413
   PubMedGoogle Scholar
• Schmidt M, Schmidt SAJ, Adelborg K, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563–591. doi:10.2147/CLEP.S179083
   PubMed Web of Science ®Google Scholar
• Nørgaard M, Johnsen SP. How can the research potential of the clinical quality databases be maximized? The Danish experience. J Intern Med. 2016;279(2):132–140. doi:10.1111/joim.12437
   PubMed Web of Science ®Google Scholar
• Thygesen LC, Ersbøll AK. When the entire population is the sample: strengths and limitations in register-based epidemiology. Eur J Epidemiol. 2014;29(8):551–558. doi:10.1007/s10654-013-9873-0
   PubMed Web of Science ®Google Scholar
• Daugaard G, Kier M, Bandak M, et al. The Danish testicular cancer database. Clin Epidemiol. 2016;8:703–707. doi:10.2147/CLEP.S99493
   PubMed Web of Science ®Google Scholar
• Datecadatabase. Annual report (in Danish); 2021. Available from: https://www.sundhed.dk/content/cms/86/15686_dateca-aarsrapport-2021_offentlig-version.pdf. Accessed November 14, 2022.
   Google Scholar
• Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish national patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. doi:10.2147/CLEP.S91125
   PubMed Web of Science ®Google Scholar
• Erichsen R, Lash TL, Hamilton-Dutoit SJ, Bjerregaard B, Vyberg M, Pedersen L. Existing data sources for clinical epidemiology: the Danish national pathology registry and data bank. Clin Epidemiol. 2010;2(1):51–56. doi:10.2147/CLEP.S9908
   PubMedGoogle Scholar
• Rasmussen LA, Jensen H, Virgilsen LF, et al. Identification of endometrial cancer recurrence – a validated algorithm based on nationwide Danish registries. Acta Oncol. 2021;60(4):452–458. doi:10.1080/0284186X.2020.1859133
   PubMed Web of Science ®Google Scholar
• Rasmussen LA, Jensen H, Virgilsen LF, Jensen JB, Vedsted P. A validated algorithm to identify recurrence of bladder cancer: a register-based study in Denmark. Clin Epidemiol. 2018;10:1755–1763. doi:10.2147/CLEP.S177305
   PubMed Web of Science ®Google Scholar
• Rasmussen LA, Jensen H, Virgilsen LF, Rosenkrantz L, Hölmich VP. A validated register-based algorithm to identify patients diagnosed with recurrence of malignant melanoma in Denmark. Clin Epidemiol. 2021;13:207–214. doi:10.2147/CLEP.S295844
   PubMed Web of Science ®Google Scholar
• Aagaard Rasmussen L, Jensen H, Flytkjær Virgilsen L, Jellesmark Thorsen LB, Vrou Offersen B, Vedsted P. A validated algorithm for register-based identification of patients with recurrence of breast cancer – based on Danish Breast Cancer Group (DBCG) data. Cancer Epidemiol. 2019;59(January 2019):129–134. doi:10.1016/j.canep.2019.01.016
   PubMedGoogle Scholar
• Lash TL, Riis AH, Ostenfeld EB, Erichsen R, Vyberg M, Thorlacius-Ussing O. A validated algorithm to ascertain colorectal cancer recurrence using registry resources in Denmark. Int J Cancer. 2015;136(9):2210–2215. doi:10.1002/ijc.29267
   PubMed Web of Science ®Google Scholar
• Pedersen RN, Öztürk B, Mellemkjær L, et al. Validation of an algorithm to ascertain late breast cancer recurrence using Danish medical registries. Clin Epidemiol. 2020;12:1083–1093. doi:10.2147/CLEP.S269962
   PubMed Web of Science ®Google Scholar
• Pedersen CB. The Danish civil registration system. Scand J Public Health. 2011;39(7):22–25. doi:10.1177/1403494810387965
   PubMed Web of Science ®Google Scholar
• Datecadatabase. National guidelines (in Danish); 2022. Available from: https://www.dmcg.dk/siteassets/kliniske-retningslinjer---skabeloner-og-vejledninger/kliniske-retningslinjer-opdelt-pa-dmcg/dateca/dateca_testikel-kraft_v2.0_admgodk041121.pdf. Accessed March 30, 2023.
   Google Scholar
• Oldenburg J, Berney DM, Bokemeyer C, et al. Testicular seminoma and non-seminoma: ESMO-EURACAN clinical practice guideline for diagnosis, treatment and follow-up ☆. Ann Oncol. 2022;33(4):362–375. doi:10.1016/j.annonc.2022.01.002
   PubMed Web of Science ®Google Scholar
• Wagner T, Toft BG, Engvad B, et al. Prognostic factors for relapse in patients with clinical stage I testicular cancer: protocol for a Danish nationwide cohort study. BMJ Open. 2019;9(10):1–9. doi:10.1136/bmjopen-2019-033713
   PubMed Web of Science ®Google Scholar
• Bjerregaard B, Larsen OB. The Danish pathology register. Scand J Public Health. 2011;39(7):72–74. doi:10.1177/1403494810393563
   PubMedGoogle Scholar
• Honecker F, Aparicio J, Berney D, et al. ESMO consensus conference on testicular germ cell cancer: diagnosis, treatment and follow-up. Ann Oncol. 2018;29(8):1658–1686. doi:10.1093/annonc/mdy217
   PubMed Web of Science ®Google Scholar
• Ciol MA, Hoffman JM, Dudgeon BJ, Shumway-Cook A, Yorkston KM, Chan L. Understanding the use of weights in the analysis of data from multistage surveys. Arch Phys Med Rehabil. 2006;87(2):299–303. doi:10.1016/j.apmr.2005.09.021
   PubMed Web of Science ®Google Scholar
• Mortensen MS, Lauritsen J, Gundgaard MG, et al. A nationwide cohort study of stage I seminoma patients followed on a surveillance program. Eur Urol. 2014;66(6):1172–1178. doi:10.1016/j.eururo.2014.07.001
   PubMed Web of Science ®Google Scholar
• Daugaard G, Gundgaard MG, Mortensen MS, et al. Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort. J Clin Oncol. 2014;32(34):3817–3823. doi:10.1200/JCO.2013.53.5831
   PubMed Web of Science ®Google Scholar
• Kier MG, Lauritsen J, Mortensen MS, et al. Prognostic factors and treatment results after bleomycin, etoposide, and cisplatin in germ cell cancer: a population-based study. Eur Urol. 2017;71(2):290–298. doi:10.1016/j.eururo.2016.09.015
   PubMed Web of Science ®Google Scholar
• Chovanec M, Lauritsen J, Bandak M, et al. Late adverse effects and quality of life in survivors of testicular germ cell tumour. Nat Rev Urol. 2021;18(4):227–245. doi:10.1038/s41585-021-00440-w
   PubMed Web of Science ®Google Scholar